Cambridge Investment Research Advisors’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-425
| Closed | -$128K | – | 3109 |
|
|
2022
Q1 | $128K | Hold |
425
| – | – | ﹤0.01% | 2975 |
|
|
2021
Q4 | $150K | Sell |
425
-8
| -2% | -$2.82K | ﹤0.01% | 2963 |
|
|
2021
Q3 | $111K | Buy |
+433
| New | +$111K | ﹤0.01% | 2938 |
|
|
2021
Q2 | – | Sell |
-240
| Closed | -$208K | – | 3121 |
|
|
2021
Q1 | $208K | Sell |
240
-100
| -29% | -$86.7K | ﹤0.01% | 2585 |
|
|
2020
Q4 | $315K | Sell |
340
-80
| -19% | -$74.1K | ﹤0.01% | 2092 |
|
|
2020
Q3 | $432K | Sell |
420
-39
| -8% | -$40.1K | ﹤0.01% | 1700 |
|
|
2020
Q2 | $465K | Buy |
459
+5
| +1% | +$5.07K | ﹤0.01% | 1598 |
|
|
2020
Q1 | $394K | Sell |
454
-4
| -0.9% | -$3.47K | ﹤0.01% | 1510 |
|
|
2019
Q4 | $491K | Buy |
458
+12
| +3% | +$12.9K | ﹤0.01% | 1589 |
|
|
2019
Q3 | $412K | Hold |
446
| – | – | ﹤0.01% | 1631 |
|
|
2019
Q2 | $504K | Buy |
+446
| New | +$504K | ﹤0.01% | 1417 |
|